MedPath

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Phase 2
Completed
Conditions
Immune Thrombocytopenic Purpura
Interventions
Registration Number
NCT00718692
Lead Sponsor
Symphogen A/S
Brief Summary

This trial is designed as a multi-centre, single-dose, exploratory dose-finding, open label trial evaluating the safety and efficacy of Sym001 in 4-9 consecutive cohorts. Subjects will receive a single IV dose of Sym001.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Confirmed presence of thrombocytopenia with platelet count < 30,000/mm3 at the pre-dose visit.
  • History of isolated ITP
  • RhD-positive serology.
  • Previous treatment and response to first line therapy for ITP
Exclusion Criteria
  • Known clinical picture suggestive of other causes of thrombocytopenia, especially systematic lupus erythematosus,antiphospholipid syndrome, Evans syndrome, immunodeficiency states, lymphoproliferative disorders, liver disease,ingestion of drugs such as quinidine/quinine, heparin and sulfonamides and hereditary thrombocytopenia confirmed by relevant laboratory findings.
  • Suspected infection with HIV, Hepatitis C, H. pylori.
  • Clinical splenomegaly
  • History of abnormal bone marrow examination.
  • Ongoing haemorrhage corresponding to a grade 3 or 4 on the WHO bleeding scale.
  • Underlying haemolytic condition
  • History of splenectomy.
  • Subject is pregnant, breast feeding or intends to become pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Sym001Patients treated with Sym001
Primary Outcome Measures
NameTimeMethod
Incidence and severity of Adverse Events (AEs), including Serious Adverse Events (SAEs)6 weeks post dosing
Secondary Outcome Measures
NameTimeMethod
Measurements of platelet countsFrom day 1 through week 6

Trial Locations

Locations (59)

Reseach Site 4908

🇩🇪

Halle, Germany

Aysha Hospital Pvt. Ltd., 9109

🇮🇳

Chennai, India

Apollo Hospital, 9104

🇮🇳

Hyderabad, India

Univ Nebraska Med Ctr. UNMC, 1005

🇺🇸

Omaha, Nebraska, United States

2085 Henry Tecklenburg Drive, 1001

🇺🇸

Charleston, South Carolina, United States

Research Site 3203

🇧🇪

Brugge, Belgium

Research Site 3202

🇧🇪

Leuven, Belgium

St. John's Medical College Hospital, 9106

🇮🇳

Bangalore, India

Research Site 4906, 4907

🇩🇪

Berlin, Germany

Research Site 3201

🇧🇪

Yvoir, Belgium

Kasturba Medical College Hospital, 9103

🇮🇳

Udupi, India

Bnai-Zion Medical Center, 9721

🇮🇱

Haifa, Israel

Rambam Medical Center, 9723

🇮🇱

Haifa, Israel

Western Galilee - Nahariya Hospital, 9722

🇮🇱

Nahariya, Israel

Rabin Medical Center, 9724

🇮🇱

Petach Tikva, Israel

Tel-Aviv Sourasky Medical Center, 9726

🇮🇱

Tel Aviv, Israel

Research site 4801

🇵🇱

Gdansk, Poland

Spitalul Clinic de Urgente Sfantu Spiridon, 4004

🇷🇴

Iasi, Romania

Regional Clinical Hospital of Nizhny Novgorod, 7003

🇷🇺

Nizhny Novgorod, Russian Federation

Regional Clinical Hospital na MI Kalinin, 7005

🇷🇺

Samara, Russian Federation

City Hospital #9 Kyiv Clinical Hospital, 3904

🇺🇦

Kiev, Ukraine

Vinnytsya Regional Clinical Hospital, 3902

🇺🇦

Vinnytsya, Ukraine

The Edith Wolfson Medical Center, 9725

🇮🇱

Holon, Israel

"Prof. Dr. Ion Chiricuta" Oncolgy Institute, 4001

🇷🇴

Cluj-Napoca, Romania

Royal Victoria Infirmery, 4404

🇬🇧

Newcastle Upon Tyne, United Kingdom

Singleton Hospital, 4405

🇬🇧

Swansea, United Kingdom

Research Site 4806

🇵🇱

Krakow, Poland

Research Site 4903

🇩🇪

Duisburg, Germany

Research Site 4901

🇩🇪

Hannover, Germany

Hospital of the University of Pennsylvania, Site 1002

🇺🇸

Philadelphia, Pennsylvania, United States

Research Site 4905

🇩🇪

Essen, Germany

Research Site 4902

🇩🇪

Köln, Germany

Research Site 4904

🇩🇪

Regensburg, Germany

Narayana Hrudayalaya Hospitals, 9105

🇮🇳

Bangalore, India

MS Ramaiah Memorial Hospital, 9108

🇮🇳

Bangalore, India

Columbia Asia Referral Hospital-Yeshwanthpur, 9101

🇮🇳

Bangalore, India

Research Site 4804

🇵🇱

Wroclaw, Poland

Hammersmith Hosptial, 4402

🇬🇧

London, United Kingdom

Research Site 4805

🇵🇱

Lodz, Poland

Institutul Clinic Fundeni, 4003

🇷🇴

Bucuresti, Romania

Clinical Center Zemun 3803

🇷🇸

Zemun, Serbia

Cherkassy regional oncology center, 3906

🇺🇦

Cherkassy, Ukraine

Hospital Gregorio Maranon, 3405

🇪🇸

Madrid, Spain

Research Site 4803

🇵🇱

Warszava, Poland

Instytut Hematologii i Transfuzjologii, 4807

🇵🇱

Warszawa, Poland

Brasov Country Hospital, 4002

🇷🇴

Brasov, Romania

Clinical Center Nis 3802

🇷🇸

Nis, Serbia

Research Site 3402

🇪🇸

Valencia, Spain

University College, 4401

🇬🇧

London, United Kingdom

Research Site 3401

🇪🇸

Madrid, Spain

Research Site 4802, 4808

🇵🇱

Warszawa, Poland

Saint Petersburg State Institution Of Healthcare, 7001

🇷🇺

St. Petersburg, Russian Federation

State Healthcare Institution Tula Regional Clin. Hosp., 7002

🇷🇺

Tula, Russian Federation

Clinical center Vojvodina 3801

🇷🇸

Novi Sad, Serbia

Reseach Site 3403

🇪🇸

Barcelona, Spain

Hospital La Princesa, 3404

🇪🇸

Madrid, Spain

Gusak Academy of AMS Ukraine, 3905

🇺🇦

Donetsk, Ukraine

St. James's University Hospital, 4403

🇬🇧

Leeds, United Kingdom

Khmelnytskyi Regional Hospital, 3903

🇺🇦

Khmelnytskyi, Ukraine

© Copyright 2025. All Rights Reserved by MedPath